OACC Oaktree Acquisition Corp. III Life Sciences
USFinancial ServicesAs of 2026-07-10 10:43
Why OACC matters now
Oaktree Acquisition Corp. III Life Sciences (OACC) is a US stock in Financial Services. The latest InvestLog snapshot shows $10.74 with +0.48% on the session and $264.0M in market capitalization; recent performance reads 1-month -0.47% and YTD +0.66%.
The latest financial table shown here is Q1 2026, with revenue of $0.00, net income of $1.4M, and EPS of $0.06. Investors can compare that operating picture with valuation signals such as P/E 35.75 and FCF yield -0.2%.
The latest indexable market news headline is "Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Stock Price Down 0.2% – Here’s Why" from Defense World.
Valuation
P/E (TTM)
35.75
PEG
—
P/B
1.04
P/S
0.00
EV/EBITDA
-215.78
DCF Value
—
FCF Yield
-0.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
3.6%
ROA
3.4%
ROIC
-0.6%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $0.00 | $1.4M | $0.06 |
| Q4 2025 | $0.00 | $1.8M | $0.07 |
| FY 2025 | $0.00 | $7.3M | $0.30 |
| Q3 2025 | $0.00 | $2.0M | $0.08 |
Related Stocks
Latest News
Company Info
Sector
Financial Services
Industry
Shell Companies
Country
US
Exchange
—
Beta
-0.04
Oaktree Acquisition Corp. III Life Sciences is dedicated to completing a strategic business combination, such as a merger, asset acquisition, share purchase, reorganization, or similar transaction, with one or more companies. The firm's focus is on identifying and acquiring entities within the biopharmaceutical, medical device, diagnostics, and specialized healthcare services industries located across North America and Europe. This company was formed in 2024 and is headquartered in Los Angeles, California.